Sign In
Buy WST
$316.31
+4.14 (+1.33%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (
NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) announces that, on May 5, 2025, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client the New
3 Dividend Aristocrat Stocks To Buy in May and Hold Forever
03:26pm, Monday, 05'th May 2025
Instead of selling, you can buy these dividend stocks in May and go away. These Dividend Aristocrat stocks have both upside potential and pay dividends.
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (
NEW YORK, NY / ACCESS Newswire / May 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
07:30am, Wednesday, 30'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc."
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST
07:30am, Tuesday, 29'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc."
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc."
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag
04:06pm, Thursday, 24'th Apr 2025
West Pharmaceutical Services, Inc. WST on Thursday reported first-quarter 2025 adjusted EPS of $1.45, beating the consensus of $1.23.
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript
03:52pm, Thursday, 24'th Apr 2025
West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit
12:40pm, Thursday, 24'th Apr 2025
West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates
08:15am, Thursday, 24'th Apr 2025
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.56 per share a year ago
Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST
07:25am, Thursday, 24'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc."
West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies
07:13am, Thursday, 24'th Apr 2025
West Pharmaceutical Services raised its annual profit forecast on Thursday, anticipating a boost from a weaker dollar to shield it from a potential hit from U.S. President Donald Trump's tariffs.
